These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8080904

  • 21. Growth hormone response to clonidine in untreated depressed patients.
    Schittecatte M, Charles G, Machowski R, Wilmotte J.
    Psychiatry Res; 1989 Aug; 29(2):199-206. PubMed ID: 2798598
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Growth hormone response to growth hormone releasing hormone in depression and schizophrenia.
    Peabody CA, Warner MD, Markoff E, Hoffman AR, Wilson DM, Csernansky JG.
    Psychiatry Res; 1990 Sep; 33(3):269-76. PubMed ID: 2243902
    [Abstract] [Full Text] [Related]

  • 25. Interaction of clonidine and GHRH on GH secretion in vivo and in vitro.
    Alba-Roth J, Losa M, Spiess Y, Schopohl J, Müller OA, von Werder K.
    Clin Endocrinol (Oxf); 1989 May; 30(5):485-91. PubMed ID: 2514051
    [Abstract] [Full Text] [Related]

  • 26. Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism.
    Giustina A, Buffoli MG, Bussi AR, Wehrenberg WB.
    Horm Res; 1991 May; 36(5-6):192-5. PubMed ID: 1823078
    [Abstract] [Full Text] [Related]

  • 27. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects.
    Hanew K, Tanaka A, Utsumi A, Sugawara A, Abe K.
    J Clin Endocrinol Metab; 1996 May; 81(5):1952-5. PubMed ID: 8626863
    [Abstract] [Full Text] [Related]

  • 28. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
    Gann H, Riemann D, Stoll S, Berger M, Müller WE.
    Pharmacopsychiatry; 1995 May; 28(3):80-3. PubMed ID: 7568369
    [Abstract] [Full Text] [Related]

  • 29. Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents.
    Laron Z, Bowers CY, Hirsch D, Almonte AS, Pelz M, Keret R, Gil-Ad I.
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):424-6. PubMed ID: 8279223
    [Abstract] [Full Text] [Related]

  • 30. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F, Dieguez C, Casanueva FF.
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [Abstract] [Full Text] [Related]

  • 31. Growth hormone response to growth hormone-releasing hormone and clonidine in young monkeys: correlation with behavioral characteristics.
    Coleman K, Dahl RE, Ryan ND, Cameron JL.
    J Child Adolesc Psychopharmacol; 2003 May; 13(3):227-41. PubMed ID: 14642012
    [Abstract] [Full Text] [Related]

  • 32. Comparative effect of clonidine and growth hormone (GH)-releasing hormone on GH secretion in adult patients on chronic glucocorticoid therapy.
    Giustina A, Buffoli MG, Bussi AR, Doga M, Girelli A, Pizzocolo G, Pozzi A, Wehrenberg WB.
    Horm Metab Res; 1992 May; 24(5):240-3. PubMed ID: 1398465
    [Abstract] [Full Text] [Related]

  • 33. Noradrenergic receptor sensitivity in obsessive-compulsive disorders: I. Growth hormone response to clonidine stimulation.
    Brambilla F, Perna G, Bellodi L, Arancio C, Bertani A, Perini G, Carraro C, Gava F.
    Psychiatry Res; 1997 Mar 24; 69(2-3):155-62. PubMed ID: 9109183
    [Abstract] [Full Text] [Related]

  • 34. Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency.
    Gelato MC, Malozowski S, Caruso-Nicoletti M, Ross JL, Pescovitz OH, Rose S, Loriaux DL, Cassorla F, Merriam GR.
    J Clin Endocrinol Metab; 1986 Jul 24; 63(1):174-9. PubMed ID: 3086356
    [Abstract] [Full Text] [Related]

  • 35. Growth hormone (GH) response to GH-releasing hormone in depression.
    Lesch KP, Laux G, Pfüller H, Erb A, Beckmann H.
    J Clin Endocrinol Metab; 1987 Dec 24; 65(6):1278-81. PubMed ID: 3119657
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J, Diaz MJ, Tresguerres JA, Arce V, Lima L.
    J Clin Endocrinol Metab; 1991 Aug 24; 73(2):251-6. PubMed ID: 1677361
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.